Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Journal of Inherited Metabolic Disease
|
October 25, 2008
Tetrahydrobiopterin deficiency in human rabies
R E Willoughby, T Opladen, T Maier, et al.
Human Genetics
|
August 1, 1991
The most common mutation causing medium-chain acyl-CoA dehydrogenase deficiency is strongly associated with a particular haplotype in the region of the gene
S Kølvraa, N Gregersen, A I Blakemore, et al.
Journal of Clinical Pharmacology
|
June 19, 2013
Population pharmacokinetic modeling and dosing simulations of nitrogen-scavenging compounds: disposition of glycerol phenylbutyrate and sodium phenylbutyrate in adult and pediatric patients with urea cycle disorders
Jon P R Monteleone, M Mokhtarani, G A Diaz, et al.
Molecular Genetics and Metabolism
|
May 27, 2011
Ammonia control in children with urea cycle disorders (UCDs); phase 2 comparison of sodium phenylbutyrate and glycerol phenylbutyrate
Uta Lichter-Konecki, G A Diaz, J L Merritt, et al.
Journal of Inherited Metabolic Disease
|
November 1, 2002
Phenylketonuria in adulthood: a collaborative study
R Koch, B Burton, G Hoganson, et al.
Molecular Genetics and Metabolism
|
November 21, 2015
Glutamine and hyperammonemic crises in patients with urea cycle disorders
B Lee, G A Diaz, W Rhead, et al.
Molecular Genetics and Metabolism
|
October 23, 2013
Elevated phenylacetic acid levels do not correlate with adverse events in patients with urea cycle disorders or hepatic encephalopathy and can be predicted based on the plasma PAA to PAGN ratio
M Mokhtarani, G A Diaz, W Rhead, et al.
Molecular Genetics and Metabolism
|
September 11, 2012
Urinary phenylacetylglutamine as dosing biomarker for patients with urea cycle disorders
M Mokhtarani, G A Diaz, W Rhead, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Journal of Inherited Metabolic Disease
|
October 25, 2008
Tetrahydrobiopterin deficiency in human rabies
R E Willoughby, T Opladen, T Maier, et al.
Human Genetics
|
August 1, 1991
The most common mutation causing medium-chain acyl-CoA dehydrogenase deficiency is strongly associated with a particular haplotype in the region of the gene
S Kølvraa, N Gregersen, A I Blakemore, et al.
Journal of Clinical Pharmacology
|
June 19, 2013
Population pharmacokinetic modeling and dosing simulations of nitrogen-scavenging compounds: disposition of glycerol phenylbutyrate and sodium phenylbutyrate in adult and pediatric patients with urea cycle disorders
Jon P R Monteleone, M Mokhtarani, G A Diaz, et al.
Molecular Genetics and Metabolism
|
May 27, 2011
Ammonia control in children with urea cycle disorders (UCDs); phase 2 comparison of sodium phenylbutyrate and glycerol phenylbutyrate
Uta Lichter-Konecki, G A Diaz, J L Merritt, et al.
Journal of Inherited Metabolic Disease
|
November 1, 2002
Phenylketonuria in adulthood: a collaborative study
R Koch, B Burton, G Hoganson, et al.
Molecular Genetics and Metabolism
|
November 21, 2015
Glutamine and hyperammonemic crises in patients with urea cycle disorders
B Lee, G A Diaz, W Rhead, et al.
Molecular Genetics and Metabolism
|
October 23, 2013
Elevated phenylacetic acid levels do not correlate with adverse events in patients with urea cycle disorders or hepatic encephalopathy and can be predicted based on the plasma PAA to PAGN ratio
M Mokhtarani, G A Diaz, W Rhead, et al.
Molecular Genetics and Metabolism
|
September 11, 2012
Urinary phenylacetylglutamine as dosing biomarker for patients with urea cycle disorders
M Mokhtarani, G A Diaz, W Rhead, et al.
Page
of 2